Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: A survey of the European Group for Blood and Marrow Transplantation (EBMT)

Bone Marrow Transplantation

Volumn 35, Issue 2, 2005, Pages 121-124

  Ruutu, Tapani ^a   Corradini, P ^b   Gratwohl, A ^c   Holler, E ^d   Apperley, J ^e   Dini, G ^f   Rocha, V ^g   Schmitz, N ^h   Socie G ^g   Niederwieser, D ⁱ  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^f G GASLINI INSTITUTE   (Italy)

^g SAINT LOUIS HOSPITAL   (France)

^h AK St Georg ^*  (Germany)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Allogeneic stem cell transplantation; Intrathecal prophylaxis; Malignant blood disease

Indexed keywords

CORTICOSTEROID; CYTARABINE; FOLINIC ACID; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM METASTASIS; DRUG INDICATION; EUROPE; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; LYMPHOMA; MEDICAL LITERATURE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DATA COLLECTION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INJECTIONS, SPINAL; LEUKEMIA; LYMPHOMA; PREMEDICATION; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 19944433345     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704727     Document Type: Article

References (12)

1. Mellett LB. Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep 1977; 61: 527-531.
2. Vassal G. Alkylating agents: cyclophosphamide, ifosfamide, melphalan, thiotepa, chlorambucil, busulfan. In: Cvitkovic E, Droz JP, Armand JP, Khouri S (eds). Handbook of Chemotherapy in Clinical Oncology. Scientific Communication International Ltd: Jersey, Channel Islands, 1993, pp 221-232.
3. Hassan M, Öberg G, Ehrsson H et al. Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol 1989; 36: 525-530.
4. Thompson CB, Sanders JE, Flournoy N et al. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 1986; 67 195-199.
5. Ganem G, Kuenz M, Bernaudin F et al. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer 1989; 64: 1796-1804.
6. Singhal S, Powles R, Treleaven J et al. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 1996; 17: 637-641.
7. Asato R, Akiyama Y, Ito M et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylatic treatment with intrathecal methotrexate. Cancer 1992; 70: 1997-2004.
8. Hoelzer D. Leukenzephalopathie nach intrathekaler Zytostatikagabe bei akuter lymphatischer Leukämie. Dtsch Med Wochenschr 1994; 119: 1637.
9. Mahoney Jr DH, Shuster JJ, Nitschke R et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - a Pediatric Oncology Group Study. J Clin Oncol 1998; 16: 1712-1722.
10. Staudinger T, Heinberger K, Rabitch W et al. Subdural hygromas after bone marrow transplantation. Transplantation 1998; 65: 1340-1344.
11. Hentschke P, Hägglund H, Mattsson J et al. Bilateral subdural haematomas following lumbar puncture in three haematopoetic stem cell transplantation recipients. Bone Marrow Transplant 1999; 24 1033-1035.
12. Colosimo M, McCarthy N, Jayasinghe R et al. Diagnosis and management of subdural haematoma complicating bone marrow transplantation. Bone Marrow Transplant 2000; 25: 549-552.